| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
PASADENA, Calif.—Nanostream Inc. earlier this month rolled out a fraction collector add-on to it Veloce micro parallel liquid chromatography system. The fraction collector was developed in response to customers who were looking to take advantage of the Veloce system as a sample preparation device for mass spec applications.
 
"I've always believed that the way you develop a technology is to make sure the first version solves a problem and then you let customers drive you to the next thing," says Steve O'Connor, CEO and founder of Nanostream. "That is what happened here."
 
The fraction collector automates front-end sample preparation for researchers to help them accelerate routine assays that require MS, MS/MS or other, alternate modes of detection. The hope at Nanostream is that the Veloce system, along with the fraction collector can help drug discovery researchers move ADME to earlier in the discovery cycle.
 
But in order to move ADME, and specifically DMPK, to earlier in the process, there needs to be an increase in throughput. "ADME is responsible for a large portion of attrition and DMPK, especially, is a real bottleneck," says Surekha Vajjhala, director of marketing for Nanostream.
 
According to the company, increased throughput is created by taking separations offline. This decoupling of the chromatography from detection and quantitation allows researchers to get more "up" time from their MS instrumentation.
 
"There are a range of applications that can benefit from this," Vajjhala adds. "This includes drug-drug interaction studies, pharmacokinetic profiling, stability assays and others."

About the Author

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue